Page last updated: 2024-10-25

clonidine and Brain Diseases

clonidine has been researched along with Brain Diseases in 10 studies

Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.

Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.

Research Excerpts

ExcerptRelevanceReference
" Wide interpatient variability in the effective plasma concentrations of tizanidine means that the optimal dosage must be titrated over 2 to 4 weeks for each patient (dosages of 2 to 36 mg/day have been used in clinical trials)."2.40Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders. ( Bryson, HM; Wagstaff, AJ, 1997)
"Posterior reversible encephalopathy syndrome (PRES) is an acronym that identifies a new clinico-neuroradiologic entity occurring in association with different conditions."1.33PRES: posterior or potentially reversible encephalopathy syndrome? ( Abbate, M; Ferlazzo, E; Granata, F; Mazzù, I; Musolino, R; Narbone, MC, 2006)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19907 (70.00)18.7374
1990's2 (20.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Narbone, MC1
Musolino, R1
Granata, F1
Mazzù, I1
Abbate, M1
Ferlazzo, E1
Ram, CV2
Lai, YY1
Chan, SH1
O'Connor, DT1
Cervenka, JH1
Stone, RA1
Parmer, RJ1
Franco-Bourland, RE1
Madrazo, I1
Langlais, PJ1
Wagstaff, AJ1
Bryson, HM1
Feldstein, JS1
Barbeito, L1
Fernández, C1
Silveira, R1
Dajas, F1
Meese, RB1
Rozniecki, J1
Persico, L1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Clinical Effect and Sonographic Findings of Kinesiotaping Combined With Therapeutic Exercise in Upper Extremity Spasticity and Function in Subacute Stroke Patients[NCT03024190]36 participants (Actual)Interventional2017-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for clonidine and Brain Diseases

ArticleYear
Hypertensive crisis.
    Cardiology clinics, 1984, Volume: 2, Issue:2

    Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Dia

1984
Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.
    Drugs, 1997, Volume: 53, Issue:3

    Topics: Adrenergic alpha-Agonists; Animals; Brain Diseases; Clinical Trials as Topic; Clonidine; Humans; Mus

1997
Hypertensive cardiovascular emergencies.
    Comprehensive therapy, 1985, Volume: 11, Issue:10

    Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Dia

1985

Other Studies

7 other studies available for clonidine and Brain Diseases

ArticleYear
PRES: posterior or potentially reversible encephalopathy syndrome?
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2006, Volume: 27, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Anticonvulsants; Antihypertensive Agents; Brain; Brain Diseases; Cl

2006
Antagonization of clonidine- and morphine-promoted antinociception by kainic acid lesion of nucleus reticularis gigantocellularis in the rat.
    Experimental neurology, 1982, Volume: 78, Issue:1

    Topics: Animals; Brain Diseases; Clonidine; Kainic Acid; Male; Morphine; Nociceptors; Pain; Rats; Rats, Inbr

1982
Chromogranin A immunoreactivity in human cerebrospinal fluid: properties, relationship to noradrenergic neuronal activity, and variation in neurologic disease.
    Neuroscience, 1993, Volume: 56, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Amino Acid Sequence; Brain Diseases; Chromogranin A; Chrom

1993
Hypertensive emergencies.
    Primary care, 1986, Volume: 13, Issue:1

    Topics: Adrenal Gland Neoplasms; Angina Pectoris; Antihypertensive Agents; Aortic Aneurysm; Aortic Dissectio

1986
Evidences of a sympatho-adrenal dysfunction after lesion of the central noradrenergic pathways in rats.
    Journal of neural transmission, 1986, Volume: 67, Issue:3-4

    Topics: Adrenal Medulla; Adrenergic Fibers; Animals; Benzylamines; Brain Diseases; Clonidine; Epinephrine; M

1986
[Less known indications for the use of clonidine].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1985, Feb-15, Volume: 38, Issue:4

    Topics: Alcohol Amnestic Disorder; Brain Diseases; Clonidine; Glaucoma; Humans; Migraine Disorders; Opioid-R

1985
[Pathogenesis and therapy of acute pulmonary edema].
    Il Policlinico. Sezione pratica, 1972, Jan-01, Volume: 79, Issue:1

    Topics: Acute Disease; Brain Diseases; Cardiac Glycosides; Clonidine; Diuretics; Gas Poisoning; Heart Defect

1972